Shenzhen Salubris Pharmaceuticals Investor
Shenzhen Salubris Pharmaceuticals Co., Ltd.Shenzhen Salubris Pharmaceuticals Co., Ltd. founded in 1998 and listed on the Shenzhen Stock Exchange in 2009 (stock code: 002294) is an innovation-driven pharmaceutical company based in China and extended worldwide, which has established a plurality of R&D centers in China and the United States covering the whole industry chain and connecting global innovative resources to study pathogenesis, explore therapies and develop innovative drugs.Shenzhen Salubris Pharmaceuticals Co., Ltd.salubris.com/en/CompanyProfile/index.htmlБыл ли этот ответ полезен?
Connections
Total Funding:
1780000000.0
Headquarters:
Shenzhen, Guangdong, China
Funding Status:
IPO
Estimated Revenue:
US$4.4 billion
Last Funding Type:
Post-IPO Equity
Last Funding Date:
2020-09-01
Founded Date:
1998-01-01
Industry:
DeepTech